SCHEMBL7822387

SCHEMBL7822387

NC(=O)C1=CC=COO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6580612 0.77 MPO (0.32)
SCHEMBL7420751 0.72 GSK3B (0.33)
SCHEMBL3641375 0.69 TSHR (0.40)
SCHEMBL4966817 0.64 CA1 (0.30)
SCHEMBL670160 0.62
SCHEMBL27537648 0.62
SCHEMBL2016425 0.62
SCHEMBL28455455 0.62
SCHEMBL7107049 0.61
Hydrochloric Acid SCHEMBL28656210 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106905247-B Acetamides and application thereof 华东理工大学 2019-05-17 CN claimed
CN-109071543-A Inhibit the pyridine derivate of RAF kinases and vascular endothelial growth factor receptor, preparation method contains its medical composition and its use 三进制药株式会社 2018-12-21 CN claimed
EP-3233087-A1 GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS Axovant Sciences GmbH (DE) 2017-10-25 EP claimed
CN-106938997-A N (4 substitution phenethyl) acetamides and application thereof 华东理工大学 2017-07-11 CN claimed
CN-106905247-A Acetamides and application thereof 华东理工大学 2017-06-30 CN claimed
WO-2016100184-A1 GEMINAL SUBSTITUTED QUINUCLIDINE AMIDE COMPOUNDS AS AGONISTS OF ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTORS FORUM PHARMACEUTICALS, INC. (US) 2016-06-23 WO claimed
CN-101990433-A Compounds that enhance atoh-1 expression BRIGHAM & WOMENS HOSPITAL 2011-03-23 CN claimed
CN-1735441-A Combination for treating attention deficit hyperactivity disorder PHARMACIA & UPJOHN CO LLC (US) 2006-02-15 CN claimed
CN-115551855-A Small molecule inhibitors of galectin-3 百时美施贵宝公司 2022-12-30 CN disclosed
CN-110092774-B Aromatic propionic acid derivative, preparation method and application thereof 中国科学院上海药物研究所 2022-04-08 CN disclosed
CN-113727988-A Small molecule inhibitors of galectin-3 百时美施贵宝公司 2021-11-30 CN disclosed
CN-113710665-A Small molecule inhibitors of galectin-3 百时美施贵宝公司 2021-11-26 CN disclosed
CN-113166122-A Small molecule inhibitors of galectin-3 百时美施贵宝公司 2021-07-23 CN disclosed
CN-109071543-B Pyridine derivatives inhibiting RAF kinase and vascular endothelial growth factor receptor, process for their preparation, pharmaceutical compositions containing them and their use 三进制药株式会社 2021-07-16 CN disclosed
EP-2603513-A1 HETEROCYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2013-06-19 EP disclosed
WO-2012020848-A1 HETEROCYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-02-16 WO disclosed
CN-101631546-A Use of spiro-indolone compounds as therapeutic agents XENON PHARMACEUTICALS INC 2010-01-20 CN disclosed
CN-1735441-A Combination for treating attention deficit hyperactivity disorder PHARMACIA & UPJOHN CO LLC (US) 2006-02-15 CN disclosed
EP-1131321-A2 INDOLE DERIVATIVES AND THEIR USE AS SEROTONIN RECEPTOR LIGANDS ELI LILLY AND COMPANY LIMITED (GB) 2001-09-12 EP disclosed
WO-2000031074-A2 INDOLE DERIVATIVES AND THEIR USE AS SEROTONIN RECEPTOR LIGANDS ELI LILLY AND COMPANY LIMITED (GB) 2000-06-02 WO disclosed